Research company Aptahem's rights issue was preliminarily subscribed to 23.7 percent, of which 22.1 percent with subscription rights and 1.6 percent without. The company will thus receive about SEK 3.3 million before issue costs. The subscription period ended on April 24 and the final outcome is expected on April 27. Trading in new shares is expected to start around week 21.